日韩中文字幕永久免费观看电剧_亚洲国产中文av网站1区_这里只有精品无卡顿_黄色影院在线观看视频_先锋音影亚洲自拍_熟妇高潮一区二区精品色欲_欧美巨大粗爽av在线观看_九九中文字幕天堂女人_亚洲国产日韩欧美综合久久_真实国产老熟女粗口
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2012.03.08
2012年第一次臨時(shí)股東大會的法律意見書
2012.03.07
關(guān)于全資子公司完成增資變更注冊的公告
2012.02.18
2011年度業(yè)績快報(bào)
2012.02.11
北京市中倫律師事務(wù)所關(guān)于公司股權(quán)激勵計(jì)劃的法律意見書
2012.02.11
北京市中倫律師事務(wù)所關(guān)于公司股票期權(quán)激勵計(jì)劃的補(bǔ)充法律意見書
2012.02.11
中國中投證券有限責(zé)任公司關(guān)于公司預(yù)計(jì)2012年度關(guān)聯(lián)交易有關(guān)事項(xiàng)的核查意見
2012.02.11
關(guān)于召開2012年第一次臨時(shí)股東大會的通知公告
2012.02.11
中國中投證券有限責(zé)任公司關(guān)于公司調(diào)整募集資金投資項(xiàng)目投資進(jìn)度有關(guān)事項(xiàng)的核查意見
2012.02.11
2012年度預(yù)計(jì)日常關(guān)聯(lián)交易公告
2012.02.11
股票期權(quán)激勵計(jì)劃（草案）修訂稿
第一頁
上一頁
136
137
138
139
140
下一頁
最后一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
